Search for Clinical Trial Results

Sponsored By

Esthesioneuroblastoma, Olfactory - 25 Studies Found

Status Study
Recruiting Study Name: Esthesioneuroblastoma: Outcomes After Treatment
Condition: Esthesioneuroblastoma, Olfactory
Date: 2015-09-13
Completed Study Name: Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer
Condition:
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • Recurrent Basal Cell Carcinoma of the
    Date: 2011-10-20
    Interventions:
    • Drug: everolimus Given PO
Completed Study Name: Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
Condition:
  • Anaplastic Thyroid Cancer
  • Insular Thyroid Cancer
  • Metastati
    Date: 2003-09-10
    Interventions: Drug: gefitinib Given orally Other Names:
Completed Study Name: Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
Condition:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Ependymoma
  • A
    Date: 2007-06-25
    Interventions:
    • Drug: bevacizumab Given IV
Active, not recruiting Study Name: Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
Condition:
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • Recurrent Basal Cell Carcinoma of the
    Date: 2007-05-03
    Interventions:
    • Drug: HPPH Given IV

Completed Study Name: Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Condition:
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • Recurrent Adenoi
    Date: 2001-09-13
    Interventions:
    • Drug: hydroxyurea Given orally
Completed Study Name: Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer
Condition:
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • Recurrent Adenoi
    Date: 2005-01-07
    Interventions:
    • Drug: erlotinib hydrochloride

Completed Study Name: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition:
  • Male Breast Cancer
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • Drug: alvespimycin hydrochloride

Completed Study Name: Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
Condition:
  • Adenocarcinoma of the Colon
  • Adenocarcinoma of the Rectum
  • A
    Date: 2006-11-08
    Interventions:
    • Drug: cetuximab Given IV
Completed Study Name: 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
Condition:
  • Advanced Adult Primary Liver Cancer
  • Carcinoma of the Appendix
  • Drug: 7-hydroxystaurosporine G
Next >>>